NBC Los Angeles14h
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
GlobalData on MSN14h
Struggling bluebird bio to go private for less than $30m
Bluebird bio will be acquired by investment firms Carlyle and SK Capital Partners, marking the end to its turbulent time as a ...
Blue Bird Corporation: An Opportunity To Hitch A Ride To Strong Upside
Blue Bird Corporation is a compelling investment due to its focus on electric school buses and attractive stock valuation despite recent performance setbacks. Read more here.
TMCnet18h
Shareholder Alert: Ademi LLP investigates whether bluebird bio, Inc. is obtaining a Fair Price for its Public Shareholders
The transaction agreement unreasonably limits competing transactions for bluebird by imposing a significant penalty if bluebird accepts a competing bid. We are investigating the conduct of bluebird's ...
The Advocate2d
Karnival Krewe de marks 38th ball, presents $515,000 to Mary Bird Perkins Cancer Center
King Ozzie Fernandez and Queen Liz Cortsen reigned over the 38th annual Karnival Krewe de Louisiane ball on Feb. 15.
Blue Bird's SWOT analysis: stock soars on EV strategy, operational gains
Blue Bird Corporation (NASDAQ:BLBD), a leading manufacturer of school buses, has been making significant strides in the electric vehicle (EV) market while improving its operational efficiency.